NO960125L - Indolpiperidinderivater - Google Patents
IndolpiperidinderivaterInfo
- Publication number
- NO960125L NO960125L NO960125A NO960125A NO960125L NO 960125 L NO960125 L NO 960125L NO 960125 A NO960125 A NO 960125A NO 960125 A NO960125 A NO 960125A NO 960125 L NO960125 L NO 960125L
- Authority
- NO
- Norway
- Prior art keywords
- ocf3
- cooh
- cooa
- replaced
- well
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19500689A DE19500689A1 (de) | 1995-01-12 | 1995-01-12 | Indolpiperidin-Derivate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO960125D0 NO960125D0 (no) | 1996-01-11 |
| NO960125L true NO960125L (no) | 1996-07-15 |
Family
ID=7751325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO960125A NO960125L (no) | 1995-01-12 | 1996-01-11 | Indolpiperidinderivater |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5670511A (xx) |
| EP (1) | EP0722942A1 (xx) |
| JP (1) | JPH08253474A (xx) |
| KR (1) | KR960029333A (xx) |
| CN (1) | CN1133840A (xx) |
| AU (1) | AU704484B2 (xx) |
| CA (1) | CA2166958A1 (xx) |
| CZ (1) | CZ9396A3 (xx) |
| DE (1) | DE19500689A1 (xx) |
| HU (1) | HUP9600071A3 (xx) |
| NO (1) | NO960125L (xx) |
| PL (1) | PL312270A1 (xx) |
| SK (1) | SK281080B6 (xx) |
| TW (1) | TW316900B (xx) |
| ZA (1) | ZA96228B (xx) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9700895D0 (en) * | 1997-01-17 | 1997-03-05 | Lilly Co Eli | Pharmaceutical compounds |
| DE19707628A1 (de) | 1997-02-26 | 1998-08-27 | Merck Patent Gmbh | Oxazolidinone |
| WO1999010346A1 (en) * | 1997-08-22 | 1999-03-04 | Eli Lilly And Company Limited | Benzothiadiazinyl-indole derivatives and their use as serotonin receptor ligands |
| US6310066B1 (en) | 1998-04-29 | 2001-10-30 | American Home Products Corp. | Antipsychotic indolyl derivatives |
| US6204274B1 (en) | 1998-04-29 | 2001-03-20 | American Home Products Corporation | Indolyl derivatives as serotonergic agents |
| US6066637A (en) * | 1998-06-19 | 2000-05-23 | American Home Products Corporation | Indolyl derivatives as serotonergic agents |
| GB9825413D0 (en) * | 1998-11-19 | 1999-01-13 | Lilly Co Eli | Pharmaceutical compounds |
| FR2788772B1 (fr) * | 1999-01-26 | 2001-03-02 | Adir | Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| CA2373855A1 (en) * | 1999-05-12 | 2000-11-23 | Solvay Pharmaceuticals B.V. | Method of treating psychotic disorders |
| ES2165274B1 (es) | 1999-06-04 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de indolilpiperidina como agentes antihistaminicos y antialergicos. |
| JP2003509509A (ja) * | 1999-09-09 | 2003-03-11 | ハー・ルンドベック・アクチエゼルスカベット | ５−アミノアルキル及び５−アミノカルボニル置換されたインドール類 |
| GB2362381A (en) * | 2000-05-18 | 2001-11-21 | Lilly Co Eli | Pharmaceutically active indolyl-piperidines |
| US6844338B2 (en) | 2000-05-18 | 2005-01-18 | Eli Lilly And Company | Piperidyindoles as serotonin receptor ligands |
| AR028945A1 (es) * | 2000-06-19 | 2003-05-28 | Lundbeck & Co As H | Derivados de indol |
| AR030357A1 (es) * | 2000-08-18 | 2003-08-20 | Lundbeck & Co As H | Derivados 4 -, 5 -, 6 - y 7-indol |
| ES2172436B1 (es) | 2000-10-31 | 2004-01-16 | Almirall Prodesfarma Sa | Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos. |
| DE10217006A1 (de) * | 2002-04-16 | 2003-11-06 | Merck Patent Gmbh | Substituierte Indole |
| WO2004069828A1 (ja) * | 2003-02-04 | 2004-08-19 | Mitsubishi Pharma Corporation | ピペリジン化合物およびその医薬用途 |
| US20050245540A1 (en) * | 2003-12-09 | 2005-11-03 | Fujisawa Pharmaceutical Co., Ltd. | New methods |
| PE20060373A1 (es) | 2004-06-24 | 2006-04-29 | Smithkline Beecham Corp | Derivados 3-piperidinil-7-carboxamida-indazol como inhibidores de la actividad cinasa de ikk2 |
| PE20060748A1 (es) | 2004-09-21 | 2006-10-01 | Smithkline Beecham Corp | Derivados de indolcarboxamida como inhibidores de quinasa ikk2 |
| ES2364488T3 (es) * | 2004-10-14 | 2011-09-05 | ABBOTT GMBH & CO. KG | Compuestos heterocíclicos adecuados para el tratamiento de trastornos que responden a la modulación del receptor de dopamina. |
| US8063071B2 (en) | 2007-10-31 | 2011-11-22 | GlaxoSmithKline, LLC | Chemical compounds |
| PE20081889A1 (es) | 2007-03-23 | 2009-03-05 | Smithkline Beecham Corp | Indol carboxamidas como inhibidores de ikk2 |
| GB0808282D0 (en) * | 2008-05-07 | 2008-06-11 | Medical Res Council | Compounds for use in stabilizing p53 mutants |
| JP2012520257A (ja) | 2009-03-10 | 2012-09-06 | グラクソ グループ リミテッド | Ｉｋｋ２阻害剤としてのインドール誘導体 |
| PL392436A1 (pl) * | 2010-09-17 | 2012-03-26 | Adamed Spółka Z Ograniczoną Odpowiedzialnością | Pochodne arylosulfonamidów do leczenia chorób odśrodkowego układu nerwowego |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2533924A1 (fr) * | 1982-10-05 | 1984-04-06 | Roussel Uclaf | Nouveaux derives du 4-(1h-indol-3-yl)a-methyl piperidine-1-ethanol, leurs sels, le procede de preparation, l'application a titre de medicaments et les compositions les renfermant |
| CA1246074A (en) * | 1984-12-05 | 1988-12-06 | Albertus H.M.T. Van Heertum | Derivatives of hydroxy- or amino-substituted (piperidinylalkyl)quinazolines |
| GB8531666D0 (en) * | 1985-12-23 | 1986-02-05 | Wyeth John & Brother Ltd | Indole derivatives |
| FR2608157B1 (fr) * | 1986-12-11 | 1989-09-08 | Roussel Uclaf | Nouveaux derives de l'azaspirodecane, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant et intermediaires |
| GB8719167D0 (en) * | 1987-08-13 | 1987-09-23 | Glaxo Group Ltd | Chemical compounds |
| FR2621588B1 (fr) * | 1987-10-08 | 1991-05-24 | Roussel Uclaf | Nouveaux derives de la 1,1-dioxo 1,2-benzoisothiazol 3-one, leur procede de preparation et leur application comme medicaments |
| DK733788A (da) * | 1988-01-14 | 1989-07-15 | Fujisawa Pharmaceutical Co | Indolylpiperidinderivater og fremgangsmaade til fremstilling deraf |
| JP2860688B2 (ja) * | 1990-03-14 | 1999-02-24 | 第一製薬株式会社 | インドール誘導体 |
| DK152090D0 (da) * | 1990-06-22 | 1990-06-22 | Lundbaek A S H | Piperidylsubstituerede indolderivater |
| FR2675801A1 (fr) * | 1991-04-24 | 1992-10-30 | Rhone Poulenc Rorer Sa | Piperidines, leur preparation et les medicaments les contenant. |
-
1995
- 1995-01-12 DE DE19500689A patent/DE19500689A1/de not_active Withdrawn
-
1996
- 1996-01-08 AU AU40862/96A patent/AU704484B2/en not_active Ceased
- 1996-01-10 CA CA002166958A patent/CA2166958A1/en not_active Abandoned
- 1996-01-10 TW TW085100253A patent/TW316900B/zh active
- 1996-01-10 SK SK43-96A patent/SK281080B6/sk unknown
- 1996-01-10 EP EP96100253A patent/EP0722942A1/de not_active Withdrawn
- 1996-01-11 ZA ZA96228A patent/ZA96228B/xx unknown
- 1996-01-11 KR KR1019960000398A patent/KR960029333A/ko not_active Application Discontinuation
- 1996-01-11 PL PL96312270A patent/PL312270A1/xx unknown
- 1996-01-11 CN CN96100424A patent/CN1133840A/zh active Pending
- 1996-01-11 CZ CZ9693A patent/CZ9396A3/cs unknown
- 1996-01-11 HU HU9600071A patent/HUP9600071A3/hu unknown
- 1996-01-11 NO NO960125A patent/NO960125L/no unknown
- 1996-01-12 JP JP8020619A patent/JPH08253474A/ja active Pending
- 1996-01-16 US US08/586,273 patent/US5670511A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1133840A (zh) | 1996-10-23 |
| TW316900B (xx) | 1997-10-01 |
| AU4086296A (en) | 1996-07-18 |
| KR960029333A (ko) | 1996-08-17 |
| HUP9600071A2 (hu) | 1998-09-28 |
| AU704484B2 (en) | 1999-04-22 |
| US5670511A (en) | 1997-09-23 |
| EP0722942A1 (de) | 1996-07-24 |
| SK281080B6 (sk) | 2000-11-07 |
| DE19500689A1 (de) | 1996-07-18 |
| JPH08253474A (ja) | 1996-10-01 |
| CZ9396A3 (en) | 1996-07-17 |
| SK4396A3 (en) | 1996-11-06 |
| PL312270A1 (en) | 1996-07-22 |
| ZA96228B (en) | 1996-07-26 |
| NO960125D0 (no) | 1996-01-11 |
| HUP9600071A3 (en) | 2000-04-28 |
| CA2166958A1 (en) | 1996-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO960125L (no) | Indolpiperidinderivater | |
| NO20083446L (no) | Fenyl-piperazinderivater som serotonin-reopptaksinhibitorer | |
| FI931765A (fi) | Steroidderivat foer behandling av prostatahypertrofi, deras framstaellning och anvaendningar | |
| ATE147071T1 (de) | 1,4-disubstituierte piperidinderivate, ihre herstellung und therapeutische verwendung | |
| NO950813L (no) | Acetamider | |
| EA200100310A1 (ru) | Кислородсодержащие гетероциклические соединения | |
| EP0396282A3 (en) | N-aryl-N-[4-(heterocyclicalkyl) piperidinyl]amides and pharmaceutical compositions and methods employing such compounds | |
| TWI367882B (en) | Preparation and use of 2-substituted-5-oxo-3-pyrazolidinecarboxylates | |
| HUP0300677A2 (hu) | Újfajta indolszármazékok, és azok gyógyszerként történő alkalmazása és eljárás az előállításukra | |
| EA200200108A1 (ru) | Производные стрептограминов, способ их получения и композиции на их основе | |
| NO974115L (no) | Nye aminoalkanfosfinsyrer og deres salter | |
| ES8700857A1 (es) | Un procedimiento para la produccion de dihidropiridinas | |
| NO943961L (no) | Sykliske aminderivater | |
| ATE151750T1 (de) | 3-(indol-3-yl) propensäurderivate, die als nmda- antagonisten nützlich sind | |
| DK109285A (da) | Laegemidler paa basis af piperidinderivater, piperidinderivater ogfremgangsmaade til deres fremstilling | |
| CA2009542A1 (en) | Cyclic guanidines as calcium antagonists | |
| NO20002837L (no) | Nye arylpiperazinylalkyl-3(2H)-pyridazinoner | |
| RS50275B (sr) | Derivati caloporosida, postupak za njihovu proizvodnju i njihova primena | |
| AU537086B2 (en) | 4-amino-2,6-diaryl-tetrahydrothiopyrans | |
| TWI256383B (en) | Anthraquinone compound | |
| ATE264320T1 (de) | 5-aminoalkyl- und 5-aminocarbonylsubstituierte indole | |
| TW338707B (en) | Pyridylacetic acid derivative with its manufacturing method and the intermediate as well as the use |